Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 826 (1), 112-6

Soluble interleukin-1 Receptor Type II Levels Are Elevated in Cerebrospinal Fluid in Alzheimer's Disease Patients

Affiliations

Soluble interleukin-1 Receptor Type II Levels Are Elevated in Cerebrospinal Fluid in Alzheimer's Disease Patients

A Garlind et al. Brain Res.

Abstract

Evidence from epidemiological, clinical and experimental studies favour the hypothesis that inflammatory events are part of the neuropathology in Alzheimer's disease. Proinflammatory cytokines such as interleukin-1 (IL-1), interleukin-6 (IL-6) and tumour necrosis factor-alpha (TNF-alpha) have been found in activated microglia in the vicinity of amyloid plaques in Alzheimer's disease brain. In the present study, the levels of soluble IL-1 receptor type II (sIL-1R type II), IL-1 receptor antagonist (IL-1ra), IL-1beta, IL-6 and TNF-alpha were analyzed in cerebrospinal fluid (CSF) samples from Alzheimer's disease patients and control subjects. The levels of sIL-1R type II were significantly higher in CSF from Alzheimer's disease patients than in CSF samples from control subjects (38.5+/-8 pg/ml (mean+/-S.E.M.) vs. 7.9+/-4 pg/ml, p<0.05). Measurements of the proinflammatory cytokines IL-6 and TNF-alpha showed no significant difference between the two groups, and the levels of IL-1beta and IL-1ra in the present material were too low to permit detection. The increased levels of sIL-1R type II may reflect a compensatory mechanism to balance an increased release of IL-1 receptor agonists in the Alzheimer's disease brain.

Similar articles

See all similar articles

Cited by 22 PubMed Central articles

See all "Cited by" articles

Publication types

LinkOut - more resources

Feedback